Using a murine model of metastatic outgrowth, loss of the mTORC1 component Raptor in endothelial cells reduced uptake of the fluorescent palmitate analog BODIPY-C16 within tumors that was associated with a decrease in metastatic tumor burden. This evidence concerns the gene RPTOR and neoplasm.